The Prospective Intersectoral National Cohort Study MYRIAM To Study Characteristics, Treatment And Outcome Of Patients With Multiple Myeloma In Germany. 20. Februar 2020 Knauf, W., Engelhardt, M., Losem, C., Lipke, J., Kasper, C., Houet, L., Medinger, T., Jänicke, M., Marschner, N., Dechow, T., Einsele, H., 2020. Oncol Res Treat, DKK 43 (suppl 1)(392), 130. Routine care of advanced breast cancer: the prospective, national research platform OPAL for patients with advanced breast cancer in Germany. Decker T., Harbeck N., Thill M., Zahn M.-O., Nusch A., Lorenz A., Söling U., Chiabudini M., Kruggel L., Jänicke M., Marschner N., Stickeler E., Wöckel… Weiterlesen Real-world testing patterns for BRAF-mutations and treatment of patients with BRAF-mutated metastatic colorectal cancer: Results from the German Tumor Registry Colorectal Cancer (TKK Registry) Zahn, M.-O., Dörfel, S, Schulz, H., Wolf, T., Vehling-Kaiser, U., Tech, S., Jänicke, M., Wetzel, N., Marschner N., 2020. Oncol Res Treat 43(suppl 1)(426), 52. Weiterlesen